Nicola Impagliazzo

[Nicola Impagliazzo @NicolaImpa]

@SignorErnesto Holy cashburn

[Nicola Impagliazzo @NicolaImpa]

@UnibapAB @MegatrendGlobal what do you think?

[Nicola Impagliazzo @NicolaImpa]

@MinotaurStocks Yeah you can just see the progress on unearned revenue and current-non current accounts receivable and you could tell that's not stopping, they were even talking about new clients for secaas on earnings call

[Nicola Impagliazzo @NicolaImpa]

@MinotaurStocks Operating income worsening since Q4 25, but I think that they aren't actually headwinds, I would love to have your opinion because I find $allt very interesting but I can't explain the sp "depression"

[Nicola Impagliazzo @NicolaImpa]

@MinotaurStocks Are there some hypothetical reasons for rhy the stock hasn't moved for a year, I've started researching $ALLT and I can't find a specific reason, maybe cause the streets think the historical biz isn't growing that much, concentrification risk, high adoption time from costumer

[Megatrend Investor 📈 @MegatrendGlobal]

When Brad Chisum, the CEO of an AI company and former Google manager says, " $OSS builds phenomenal edge systems, and working with their team was a masterclass in doing hardware right," it carries real weight. 👀👇🏻

[Anp🅰️nman @spacanpanman]

$ASTS $SPCX: Bro, what is this AST SpaceMobile?!? 😂

[Nicola Impagliazzo @NicolaImpa]

@munchPRMR I think if Merck wanted to make an offer they would have made it way back, a couple days after $tem acquired them

[Nicola Impagliazzo @NicolaImpa]

@MWM76 I'm sorry, I've explained it bad, I think that Merck have all the interest to outbid tempus offer of 16$ all stock, they can lawfully do it, and have the capacity (ps I own $tem, that's just a risk to consider, even If minimal)

[Nicola Impagliazzo @NicolaImpa]

@pennycheck @scazzoallarispo @CaesarCapitalz è se lo dice penny

[Nicola Impagliazzo @NicolaImpa]

@CaesarCapitalz @scazzoallarispo Ahahah mah figurati non ti preoccupare, è fondamentale avere culo anzi

[Eric Lefkofsky @lefkofsky]

Congratulations to @moderna_tx and @Merck on today’s positive Phase 3 results for INTerpath-001, a major milestone for melanoma treatment and the future of more personalized care.

We are proud to partner with Moderna in support of this important program, and we’re excited to see this work continue to advance for patients.

https://t.co/MVFakPblaU

[Nicola Impagliazzo @NicolaImpa]

@peonyKingOF Why not $tem

[Nicola Impagliazzo @NicolaImpa]

@scazzoallarispo

[Nicola Impagliazzo @NicolaImpa]

@AuditTheHerd I hope that this give us a little bit of momentum

[Nicola Impagliazzo @NicolaImpa]

@gloc19x @CaesarCapitalz I wasn't comparing $tem with $abcl, but $tem with $pltr for different reasons like data moat ecc...

[Nicola Impagliazzo @NicolaImpa]

@CaesarCapitalz Da più di 1 anno che la holdo, average di 55$ mai venduto nulla, neanche quando arrivò sui 100$ (un po' mi pento però vabbè)